Carbetocin at elective Cesarean delivery: A randomized controlled trial to determine the effective dose, part 2

Canadian Journal of Anesthesia

Volumn 60, Issue 11, 2013, Pages 1054-1060

  Anandakrishnan, Suresh ^a   Balki, Mrinalini ^a   Farine, Dan ^b   Seaward, Gareth ^b   Carvalho, Jose C A ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBETOCIN; CARBOPROST; OXYTOCIN; UTEROTONIC AGENT;

ADULT; BRADYCARDIA; CESAREAN SECTION; CONFERENCE PAPER; CONTROLLED STUDY; DYSPNEA; ELECTIVE SURGERY; FEMALE; FLUSHING; HEADACHE; HUMAN; HYPERTENSION; HYPOTENSION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; NAUSEA; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SPINAL ANESTHESIA; TACHYCARDIA; THORAX PAIN; UNSPECIFIED SIDE EFFECT; UTERINE ATONY; UTERUS CONTRACTION; VOMITING;

ADULT; ANESTHESIA, SPINAL; CESAREAN SECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTENSION; INCIDENCE; OXYTOCICS; OXYTOCIN; POSTPARTUM HEMORRHAGE; PREGNANCY; TREATMENT OUTCOME; UTERINE CONTRACTION;

EID: 84887495598     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-013-0028-2     Document Type: Conference Paper

References (18)

1. Cantwell R, Clutton-Brock T, Cooper G, et al. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. Br J Obstet Gynaecol 2011; 118(Suppl 1): 1-203.
2. Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth 2009; 9: 55.
3. Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg 2010; 110: 1368-73.
4. World Health Organization. WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage. Geneva: WHO; 2012 Available from URL: http://apps.who.int/iris/bitstream/10665/75411/1/9789241548502-eng.pdf (accessed April 2013).
5. Leduc D, Senikas V, Lalonde AB, Clinical Practice Obstetrics Committee, Society of Obstetricians and Gynaecologists of Canada, et al. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can 2009; 31: 980-93.
6. Sweeney G, Holbrook AM, Levine M, et al. Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, in non-pregnant women. Curr Ther Res 1990; 47: 528-40.
7. Su LL, Chong YS, Samuel M. Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2012; 4: CD005457.
8. Cordovani D, Balki M, Farine D, Seaward G, Carvalho JC. Carbetocin at elective cesarean delivery: a randomized controlled trial to find the effective dose. Can J Anesth 2012; 59: 751-7.
9. Bornkamp B, Pinheiro J, Bretz F. MCPMod: An R package for the design and analysis of dose finding studies. J Stat Software 2009; 29: 1-23.
10. Bretz F, Dette H, Pinheiro JC. Practical considerations for optimal designs in clinical dose finding studies. Stat Med 2010; 29: 731-42.
11. Bretz F, Pinheiro JC, Branson M. Combining multiple comparisons and modeling techniques in dose-response studies. Biometrics 2005; 61: 738-48.
12. Barth T, Jost K, Rychlik I. Milk-ejecting and uterotonic activities of oxytocin analogues in rats. Endocrinol Exp 1975; 9: 35-42.
13. Atke A, Vilhardt H. Uterotonic activity and myometrial receptor affinity of 1-deamino-1-carba-2-tyrosine(O-methyl)-oxytocin. Acta Endocrinol (Copenh) 1987; 115: 155-60.
14. Barth T, Slaninova J, Lebl M, Jost K. Biological activities and protracted action of carba-analogues of deamino-oxytocin with o-methyltyrosine in position 2. Coll Czech Chem Commun 1980; 45: 3045-50.
15. Hunter DJ, Schulz P, Wassenaar W. Effect of carbetocin, a long-acting oxytocin analog on the postpartum uterus. Clin Pharmacol Ther 1992; 52: 60-7.
16. Carvalho JC, Balki M, Kingdom J, Windrim R. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol 2004; 104: 1005-10.
17. Butwick AJ, Coleman L, Cohen SE, Riley ET, Carvalho B. Minimum effective bolus dose of oxytocin during elective caesarean delivery. Br J Anaesth 2010; 104: 338-43.
18. Thomas JS, Koh SH, Cooper GM. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing caesarean section. Br J Anaesth 2007; 98: 116-9.